Soleno Therapeutics Inc (SLNO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Anish Bhatnagar
Employees:
30
1235 RADIO ROAD, SUITE 110, REDWOOD CITY, CA 94065
650-213-8444

Soleno Therapeutics is a clinical-stage biopharmaceutical company. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name in May 2017.

Data derived from most recent annual or quarterly report
Market Cap 282.679 Million Shares Outstanding9.992 Million Avg 30-day Volume 218.517 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.95
Price to Revenue0.0 Debt to Equity0.0 EBITDA-26.49 Million
Price to Book Value3.5987 Operating Margin0.0 Enterprise Value25.349 Million
Current Ratio2.33 EPS Growth0.623 Quick Ratio2.201
1 Yr BETA -3.4409 52-week High/Low 30.3 / 0.85 Profit Margin0.0
Operating Cash Flow Growth4.9804 Free Cash Flow to Firm (FCFF) TTM -17.071 Million Free Cash Flow to Equity (FCFE) TTM-20.262 Million
Altman Z-Score-12.6345
View SEC Filings from SLNO instead.

View recent insider trading info

Soleno Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SLNO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLNO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-16 by PAULS MATTHEW
  • 3: filed on 2023-08-16 by PAULS MATTHEW
  • 4: filed on 2023-06-05 by Volck Birgitte
  • 4: filed on 2023-05-26 by YEN KRISTEN
  • 4: filed on 2023-05-26 by SINCLAIR ANDREW
  • 4: filed on 2023-05-26 by MELINCOFF GWEN A
  • 4: filed on 2023-05-26 by MACKANESS JAMES H
  • 4: filed on 2023-05-26 by HIRANO PATRICIA C
  • 4: filed on 2023-05-26 by ANISH BHATNAGAR
  • 4: filed on 2023-05-23 by EDELMAN JOSEPH

    • Events (8k)

  • 8-K: filed on 2023-09-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-27:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 8.01: Other Events
  • 8-K: filed on 2023-09-26:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-10:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-26:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-03:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    VIVO OPPORTUNITY, LLC

    VIVO OPPORTUNITY FUND HOLDINGS, L.P.

    • 10% Owner
    		 8,418,093 2023-10-02 3

    CARLYLE GROUP INC.

    CARLYLE HOLDINGS I GP INC.

    CARLYLE HOLDINGS I GP SUB L.L.C.

    CARLYLE HOLDINGS I L.P.

    CG SUBSIDIARY HOLDINGS L.L.C.

    TC GROUP, LLC

    CARLYLE INVESTMENT MANAGEMENT LLC

    CARLYLE GENESIS UK LLC

    ABINGWORTH LLP

    ABINGWORTH BIOVENTURES VII LP

    • 10% Owner
    		 1,531,436 2023-09-28 2

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    		 3,074,542 2023-09-26 6

    PAULS MATTHEW

    • Director
    		 0 2023-08-15 2

    MACKANESS JAMES H CHIEF FINANCIAL OFFICER

    • Officer
    		 33,570 2023-05-26 3

    ANISH BHATNAGAR CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 189,283 2023-05-26 3

    YEN KRISTEN SEE REMARKS

    • Officer
    		 33,563 2023-05-26 2

    HIRANO PATRICIA C SEE REMARKS

    • Officer
    		 37,422 2023-05-26 2

    MARIO ERNEST

    • Director
    		 0 2023-05-25 1

    HARRIS WILLIAM G

    • Director
    		 0 2023-05-25 1

    MELINCOFF GWEN A

    • Director
    		 0 2023-05-25 1

    VOLCK BIRGITTE

    • Director
    		 0 2023-05-25 1

    SINCLAIR ANDREW

    • Director
    		 0 2023-05-25 1

    CARLYLE GROUP INC.

    CARLYLE HOLDINGS I GP INC.

    CARLYLE HOLDINGS I GP SUB L.L.C.

    CARLYLE HOLDINGS I L.P.

    CG SUBSIDIARY HOLDINGS L.L.C.

    TC GROUP, LLC

    CARLYLE INVESTMENT MANAGEMENT LLC

    CARLYLE GENESIS UK LLC

    ABINGWORTH LLP

    • 10% Owner
    		 0 2023-05-08 2

    SCHULER JACK W

    • 10% Owner
    		 36,595 2022-12-09 1

    CARLYLE GROUP INC.

    CARLYLE HOLDINGS I GP INC.

    CARLYLE HOLDINGS I GP SUB L.L.C.

    CARLYLE HOLDINGS I L.P.

    CG SUBSIDIARY HOLDINGS L.L.C.

    TC GROUP, LLC

    CARLYLE INVESTMENT MANAGEMENT LLC

    CARLYLE GENESIS UK LLC

    • 10% Owner
    		 18,022,602 2022-08-01 2

    FEINBERG LARRY N

    ORACLE PARTNERS LP

    • * SEE REMARKS* SEE REMARKS
    		 No longer subject to file 2020-09-25 0

    COLLINSON STUART J

    • Director
    		 1,018 2020-07-31 0

    ABINGWORTH LLP

    • 10% Owner
    		 10,302,602 2020-06-26 0

    VIVO VENTURES V, LLC

    VIVO VENTURES FUND V, L.P.

    VIVO VENTURES V AFFILIATES FUND, L.P.

    • 10% Owner
    		 No longer subject to file 2019-12-02 0

    BIOASIA MANGEMENT LLC

    BIOASIA INVESTMENTS IV LLC

    • 10% Owner
    		 78,798 2019-05-17 0

    WOLTER JONATHAN CHIEF FINANCIAL OFFICER

    WOLTER JONATHAN CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-01-24 0

    FEINBERG LARRY N

    • 10% Owner
    		 3,688,798 2018-12-19 0

    WOLTER JONATHAN CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2018-06-15 0

    DALAL RAJEN

    • Director
    		 0 2018-06-11 0

    SHAH MAHENDRA

    • Director
    		 0 2018-06-11 0

    GLASHEEN JAMES WALTER

    • Director
    		 0 2018-06-11 0

    TP MANAGEMENT VII LLC

    TECHNOLOGY PARTNERS FUND VII LP

    TECHNOLOGY PARTNERS AFFILIATES VII LP

    • 10% Owner
    		 8,328,900 2018-03-07 0

    ENGELSEN STEINAR J

    • Director
    		 No longer subject to file 2018-02-05 0

    ENGLEMAN EDGAR

    • Director
    • 10% Owner
    		 No longer subject to file 2018-02-05 0

    KIRNON STEPHEN

    • Director
    		 No longer subject to file 2018-02-05 0

    FEINBERG LARRY N

    ORACLE PARTNERS LP

    ORACLE ASSOCIATES LLC

    ORACLE INVESTMENT MANAGEMENT INC

    • 10% Owner
    		 2,388,060 2017-12-15 0

    VIVO VENTURES V, LLC

    • 10% Owner
    		 14,286,694 2017-10-02 0

    O'TOOLE DAVID D

    • Director
    		 0 2017-04-19 0

    FORWARD V ASSOCIATES LLC

    FORWARD VENTURES V LP

    • 10% Owner
    		 7,173,976 2017-03-07 0

    WONDKA ANTHONY SEE REMARKS

    • Officer
    		 0 2016-06-08 0

    ALEXANDER W JAMES

    • Director
    		 No longer subject to file 2016-03-28 0

    EBBERS ED SEE REMARKS

    • Officer
    		 0 2015-05-15 0

    PHELPS GINA VICE PRESIDENT OF SALES

    • Officer
    		 0 2015-01-11 0

    VIVO VENTURES FUND V, L.P.

    VIVO VENTURES V AFFILIATES FUND, L.P.

    VIVO VENTURES V, LLC

    BDF IV ANNEX FUND LP

    BIOTECHNOLOGY DEVELOPMENT FUND IV LP

    BIOTECHNOLOGY DEVELOPMENT FUND IV AFFILIATES LP

    BIOASIA INVESTMENTS IV LLC

    BIOTECHNOLOGY DEVELOPMENT FUND II LP

    BIOASIA MANGEMENT LLC

    KUNG FRANK

    • 10% Owner
    		 2,894,228 2014-11-18 0

    VIVO VENTURES FUND V, L.P.

    CHA ALBERT

    ENGLEMAN EDGAR

    • Director
    • 10% Owner
    		 2,894,228 2014-11-18 0

    TEKNOINVEST VIII KS

    TEKNOINVEST VIII B (GP) AS

    TEKNOINVEST VIII GP KS

    • 10% Owner
    		 198,565 2014-11-12 0

    NABHAN ANTOUN SEE REMARKS

    • Officer
    		 0 2014-11-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    VIVO OPPORTUNITY, LLC - > 10% Owner by vivo opportunity fund holdings, l.p.

    VIVO OPPORTUNITY FUND HOLDINGS, L.P. - > 10% Owner by vivo opportunity fund holdings, l.p.

    		2023-10-04 16:30:15 -0400 2023-10-02 X 5,215,000 $2.50 a 8,418,093 indirect -2.226 2.7719 -3.6119 8.1478 3 -7.8958 25

    VIVO OPPORTUNITY, LLC - > 10% Owner by vivo opportunity fund holdings, l.p.

    VIVO OPPORTUNITY FUND HOLDINGS, L.P. - > 10% Owner by vivo opportunity fund holdings, l.p.

    		2023-10-04 16:30:15 -0400 2023-10-02 X 5,215,000 d 0 indirect

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 22:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 21:45:03 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 21:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 20:45:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 20:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 19:45:03 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 19:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 18:45:03 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 18:15:03 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 17:45:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 17:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 16:45:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 16:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 15:45:03 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 15:15:03 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 14:45:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 14:15:04 UTC -50.8057 56.1257 400000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 13:45:04 UTC -50.8057 56.1257 150000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 13:15:03 UTC -50.8057 56.1257 150000
    SOLENO THERAPEUTICS INC SLNO 2023-11-28 12:45:04 UTC -50.8057 56.1257 150000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments